Detalhe da pesquisa
1.
Digital cytology part 1: digital cytology implementation for practice: a concept paper with review and recommendations from the American Society of Cytopathology Digital Cytology Task Force.
J Am Soc Cytopathol
; 13(2): 86-96, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38158316
2.
Digital cytology part 2: artificial intelligence in cytology: a concept paper with review and recommendations from the American Society of Cytopathology Digital Cytology Task Force.
J Am Soc Cytopathol
; 13(2): 97-110, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38158317
3.
The current state of digital cytology and artificial intelligence (AI): global survey results from the American Society of Cytopathology Digital Cytology Task Force.
J Am Soc Cytopathol
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38744615
4.
Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma.
Mod Pathol
; 26(4): 511-22, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23196793
5.
Comparison of multiplanar reformatted CT lung tumor measurements to axial tumor measurement alone: impact on maximal tumor dimension and T stage.
AJR Am J Roentgenol
; 201(5): 959-63, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24147464
6.
Melanotic medullary thyroid carcinoma: A case report with review of the literature.
Diagn Cytopathol
; 51(1): E14-E20, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36056712
7.
The World Health Organization Reporting System for Lung Cytopathology.
Acta Cytol
; 67(1): 80-91, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36509066
8.
A comparative study of the genotype profiles of high-risk human papillomavirus infection in male and female HIV-positive patients and their correlation with anal cytology and biopsy.
J Am Soc Cytopathol
; 11(1): 21-30, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34625384
9.
Core needle lung biopsy specimens: adequacy for EGFR and KRAS mutational analysis.
AJR Am J Roentgenol
; 194(1): 266-9, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20028932
10.
Building a smart FNA cart: When Google meets cytology.
Cancer Cytopathol
; 128(12): 948-961, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32897627
11.
EGFR mutations in lung adenocarcinomas: clinical testing experience and relationship to EGFR gene copy number and immunohistochemical expression.
J Mol Diagn
; 10(3): 242-8, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18403609
12.
Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction.
Cancer Res
; 66(6): 2970-9, 2006 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16540645
13.
Pulmonary toxicity associated with erlotinib.
Chest
; 132(3): 1042-4, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17873198
14.
Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib.
Clin Cancer Res
; 12(3 Pt 1): 839-44, 2006 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16467097
15.
Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors.
Clin Cancer Res
; 12(21): 6494-501, 2006 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17085664
16.
Lung carcinoma in the era of personalized medicine: the role of cytology.
Acta Cytol
; 56(6): 587-9, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23207435
17.
Analytic inquiry: Molecular testing in lung cancer.
Cancer Cytopathol
; 125(S6): 470-476, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28609002
18.
Cytopathologic analysis of thyroid lesions in the pediatric population.
Diagn Cytopathol
; 34(2): 101-5, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16514673
19.
Morphologic Accuracy in Differentiating Primary Lung Adenocarcinoma From Squamous Cell Carcinoma in Cytology Specimens.
Arch Pathol Lab Med
; 140(10): 1116-20, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27552093
20.
KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib.
PLoS Med
; 2(1): e17, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15696205